v3.23.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenue    
Net sales $ 7,636
Cost of sales (1,527)
Gross profit 6,109
Operating Expenses    
Research and development (3,407,502) (2,287,587)
Selling, general and administrative (7,609,677) (4,750,883)
Total operating expenses (11,017,179) (7,038,470)
Loss From Operations (11,017,179) (7,032,361)
Other Income (Expense)    
Interest income 446,384 13,751
Foreign exchange transaction gain (loss) 12,345 (10,206)
Interest expense (8,776) (5,378)
Total other income (expense) 449,953 (1,833)
Net Loss (10,567,226) (7,034,194)
Other Comprehensive Income (Loss)    
Unrealized gain (loss) from investment 16,393 (34,171)
Foreign currency translation gain (loss) 2,096 (3,038)
Total other comprehensive income (loss) 18,489 (37,209)
Other Comprehensive Loss $ (10,548,737) $ (7,071,403)
Net Loss Per Common Share – Basic and Diluted (in Dollars per share) $ (0.24) $ (0.18)
Weighted Average Common Shares Outstanding – Basic and Diluted (in Shares) 44,090,998 38,247,059